Renal ontogeny of ifosfamide nephrotoxicity

Katarina Aleksa1, Naomi Halachmi, Shinya Ito

  • 1Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada.

Insights

Younger children are more vulnerable to ifosfamide-induced kidney damage. This study reveals age-related changes in cytochrome P450 enzyme activity, explaining ifosfamide nephrotoxicity in pediatric cancer patients.

Area of Science:

  • Pharmacology
  • Toxicology
  • Pediatric Oncology

Background:

  • Ifosfamide chemotherapy can cause kidney damage, particularly in young children.
  • The mechanisms behind this age-dependent nephrotoxicity are not fully understood.
  • Cytochrome P450 (CYP) enzymes are implicated in metabolizing ifosfamide into toxic byproducts.

Purpose of the Study:

  • To investigate the role of renal ontogeny in ifosfamide-induced nephrotoxicity.
  • To evaluate the age-dependent expression and activity of renal CYP enzymes involved in ifosfamide metabolism.
  • To determine if developmental changes in CYP activity correlate with age-related kidney damage.

Main Methods:

  • Assessed renal CYP3A and 2B22 activity in pigs from 1 day old to adulthood.
  • Measured ifosfamide metabolism by renal microsomes to 2- and 3-dechloroethylifosfamide.
  • Quantified kidney CYP3A messenger RNA expression over different age groups.

Main Results:

  • Renal CYP3A messenger RNA expression peaked in young pigs (15-60 days) and then decreased to adult levels.
  • Ifosfamide metabolism rate increased significantly from young to adult animals.
  • This is the first study to document the ontogeny of renal CYP3A and ifosfamide metabolism.

Conclusions:

  • Age-dependent ifosfamide nephrotoxicity is partly explained by developmental changes in renal CYP3A activity.
  • Ontogeny of CYP enzymes influences the production of nephrotoxic chloroacetaldehyde.
  • These findings are crucial for understanding and mitigating ifosfamide-induced kidney damage in pediatric cancer patients.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...